Roberto Cannella

@cannellaroberto.bsky.social

Assistant Professor (RTDB) UNIPA - Radiologist - University of Palermo 🇮🇹 - #SoMe for @insightsimaging.bsky.social EsgarSociety EuSoMII - #liver #HCC #LIRADS #AI #radsky #medsky

While ultrasound and alpha-fetoprotein remain widely used for surveillance, access to CEUS, MRI, PET/CT, multidisciplinary meetings, liver transplantation, locoregional therapies, and immunotherapy varies substantially across regions, particularly affecting Africa 🩻🌐

Global disparities in hepatocellular carcinoma care: insights from the ESGAR Global Abdominal Imaging Forum - European Radiology

Objectives To analyze the intercontinental differences and inequities in the management of hepatocellular carcinoma (HCC), including surveillance, diagnosis, and treatment, through the survey…

buff.ly

Global HCC care: are patients receiving the same opportunities worldwide? 🌍 Hepatocellular carcinoma care depends not only on guidelines, but also on access, to surveillance, advanced imaging, multidisciplinary expertise, and treatment.

Bild

🩺 Work–life balance in radiology isn’t one-size-fits-all. A new review explores how Baby Boomers, Gen X, Millennials, and Gen Z view work, purpose, and well-being differently—and what this means for the future of radiology teams.

Bild

Happy to share our new review article published in EJR! 📌 CT and MR evaluation of main pancreatic duct dilation: A radiologist’s guide to differentiating benign from malignant causes 📷 MPD dilation requires careful imaging-based differentiation 🔗 www.sciencedirect.com/science/arti...

CT and MR evaluation of main pancreatic duct dilation: A radiologist’s guide to differentiating benign from malignant causes

Main pancreatic duct (MPD) dilation is an imaging finding that encompasses a broad spectrum of benign and malignant etiologies. Differentiating betwee…

sciencedirect.com

"🔍 These findings suggest that LI-RADS 3 is not a uniform risk category. Integrating clinical factors with imaging features can improve risk stratification and enable more personalised surveillance strategies for patients with indeterminate liver lesions." - Kevin Fung